JPY 227.0
(-0.44%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.25 Billion JPY | -50.35% |
2022 | 4.53 Billion JPY | -7.32% |
2021 | 4.89 Billion JPY | -1.84% |
2020 | 4.99 Billion JPY | 135.83% |
2019 | 2.11 Billion JPY | 38.54% |
2018 | 1.52 Billion JPY | -16.88% |
2017 | 1.83 Billion JPY | -10.51% |
2016 | 2.05 Billion JPY | -14.03% |
2015 | 2.38 Billion JPY | -1.29% |
2014 | 2.41 Billion JPY | -18.64% |
2013 | 2.97 Billion JPY | -8.44% |
2012 | 3.24 Billion JPY | 64.83% |
2011 | 1.97 Billion JPY | 13.19% |
2010 | 1.74 Billion JPY | -6.82% |
2009 | 1.86 Billion JPY | 19.44% |
2008 | 1.56 Billion JPY | -13.15% |
2007 | 1.8 Billion JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 FY | 2.25 Billion JPY | -50.35% |
2023 Q4 | 2.25 Billion JPY | 3.49% |
2023 Q3 | 2.17 Billion JPY | -47.85% |
2023 Q2 | 4.17 Billion JPY | -0.71% |
2023 Q1 | 4.2 Billion JPY | -7.35% |
2022 Q1 | 4.91 Billion JPY | 0.34% |
2022 FY | 4.53 Billion JPY | -7.32% |
2022 Q4 | 4.53 Billion JPY | -5.4% |
2022 Q3 | 4.79 Billion JPY | -3.03% |
2022 Q2 | 4.94 Billion JPY | 0.68% |
2021 FY | 4.89 Billion JPY | -1.84% |
2021 Q1 | 4.83 Billion JPY | -3.14% |
2021 Q4 | 4.89 Billion JPY | 7.18% |
2021 Q3 | 4.57 Billion JPY | 22.05% |
2021 Q2 | 3.74 Billion JPY | -22.53% |
2020 Q1 | 2.31 Billion JPY | 9.55% |
2020 Q2 | 2.86 Billion JPY | 23.72% |
2020 Q4 | 4.99 Billion JPY | 36.6% |
2020 FY | 4.99 Billion JPY | 135.83% |
2020 Q3 | 3.65 Billion JPY | 27.37% |
2019 FY | 2.11 Billion JPY | 38.54% |
2019 Q1 | 1.38 Billion JPY | -9.45% |
2019 Q2 | 1.51 Billion JPY | 9.5% |
2019 Q3 | 1.55 Billion JPY | 2.39% |
2019 Q4 | 2.11 Billion JPY | 36.48% |
2018 Q2 | 1.75 Billion JPY | 0.36% |
2018 Q4 | 1.52 Billion JPY | -18.99% |
2018 FY | 1.52 Billion JPY | -16.88% |
2018 Q1 | 1.74 Billion JPY | -4.99% |
2018 Q3 | 1.88 Billion JPY | 7.6% |
2017 Q4 | 1.83 Billion JPY | -3.29% |
2017 FY | 1.83 Billion JPY | -10.51% |
2017 Q3 | 1.9 Billion JPY | -0.75% |
2017 Q2 | 1.91 Billion JPY | -2.95% |
2017 Q1 | 1.97 Billion JPY | -3.92% |
2016 Q4 | 2.05 Billion JPY | -11.41% |
2016 Q3 | 2.31 Billion JPY | 1.38% |
2016 Q1 | 2.15 Billion JPY | -9.8% |
2016 Q2 | 2.28 Billion JPY | 6.13% |
2016 FY | 2.05 Billion JPY | -14.03% |
2015 Q2 | 2.35 Billion JPY | 4.28% |
2015 Q1 | 2.25 Billion JPY | -6.85% |
2015 Q4 | 2.38 Billion JPY | 9.05% |
2015 Q3 | 2.19 Billion JPY | -6.82% |
2015 FY | 2.38 Billion JPY | -1.29% |
2014 Q2 | 2.53 Billion JPY | 9.53% |
2014 FY | 2.41 Billion JPY | -18.64% |
2014 Q4 | 2.41 Billion JPY | -6.65% |
2014 Q3 | 2.59 Billion JPY | 2.44% |
2014 Q1 | 2.3 Billion JPY | -22.32% |
2013 Q2 | 2.97 Billion JPY | -4.92% |
2013 Q3 | 3.08 Billion JPY | 3.94% |
2013 Q4 | 2.97 Billion JPY | -3.67% |
2013 Q1 | 3.12 Billion JPY | -3.82% |
2013 FY | 2.97 Billion JPY | -8.44% |
2012 Q1 | 2.54 Billion JPY | 29.24% |
2012 Q3 | 2.37 Billion JPY | -8.78% |
2012 Q4 | 3.24 Billion JPY | 36.57% |
2012 FY | 3.24 Billion JPY | 64.83% |
2012 Q2 | 2.6 Billion JPY | 2.37% |
2011 Q4 | 1.97 Billion JPY | 7.67% |
2011 FY | 1.97 Billion JPY | 13.19% |
2011 Q3 | 1.83 Billion JPY | 0.15% |
2011 Q2 | 1.82 Billion JPY | -10.01% |
2011 Q1 | 2.03 Billion JPY | 16.65% |
2010 Q1 | 2.04 Billion JPY | 9.72% |
2010 FY | 1.74 Billion JPY | -6.82% |
2010 Q3 | 2.02 Billion JPY | 24.69% |
2010 Q4 | 1.74 Billion JPY | -13.92% |
2010 Q2 | 1.62 Billion JPY | -20.87% |
2009 Q4 | 1.86 Billion JPY | -28.19% |
2009 Q3 | 2.6 Billion JPY | 34.76% |
2009 Q2 | 1.93 Billion JPY | 16.35% |
2009 Q1 | 1.65 Billion JPY | 6.08% |
2009 FY | 1.86 Billion JPY | 19.44% |
2008 Q4 | 1.56 Billion JPY | 2.47% |
2008 Q3 | 1.52 Billion JPY | 6.43% |
2008 Q2 | 1.43 Billion JPY | 0.0% |
2008 FY | 1.56 Billion JPY | -13.15% |
2007 FY | 1.8 Billion JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 42.14 Billion JPY | 94.652% |
DNA Chip Research Inc. | 250.12 Million JPY | -801.034% |
Cosmo Bio Company,Limited | 1.84 Billion JPY | -22.019% |
H.U. Group Holdings, Inc. | 152.84 Billion JPY | 98.526% |
FALCO HOLDINGS Co., Ltd. | 10.39 Billion JPY | 78.322% |
BML, Inc. | 40.85 Billion JPY | 94.483% |
Human Metabolome Technologies, Inc. | 656.68 Million JPY | -243.191% |